Biochemical Assays and Protein Production

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biochemical Assays

Protein Production

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. With all these diverse methods we characterise protein-ligand interactions in many ways. We need to build the assays that we need for compound screening.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

APRIL 12, 2024

For example, in describing how potency should be demonstrated for CGT products, the 2011 guidance simply stated that potency for gene therapy products is derived from “at least two biological activities for its potency: the ability to transfer a genetic sequence to a cell; and the biological effect of the expressed genetic sequence.”

Production

Production FDA Therapies Biochemical Assays

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Webinars

Stay Connected